Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMAZE HOLDINGS, INC.VINE · Entity 8599 | Interim Chief Financial Ofcr | May 03, 2023 | May 16, 2023 |
| Amergent Hospitality Group Inc.AMHG · Entity 113007 | Director | January 27, 2023 | April 07, 2023 |
| Forward Industries, Inc.FWDI · Entity 5540 | Director | March 10, 2026 | March 12, 2026 |
| Sonnet BioTherapeutics Holdings, Inc.BURG · Entity 72220 | Director | April 12, 2019 | May 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMAZE HOLDINGS, INC.
Report date May 03, 2023 · Filed May 16, 2023
This filing explicitly reported no securities owned.
Amergent Hospitality Group Inc.
Report date January 27, 2023 · Filed April 07, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 397,879 |
Reported balance
After 2023-01-27 transaction · row 1
1 source rowRow 1 · 2023-01-27 · Grant · Acquired 352,310 · Balance 397,879 F1: Non-employee director grant of RSAs, vesting immediately. |
Filing footnotes · ownership attribution and instrument terms
F1: Non-employee director grant of RSAs, vesting immediately.
Forward Industries, Inc.
Report date March 10, 2026 · Filed March 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.02 · Expires 2031-03-10 | Direct | 150,000 |
Reported balance
After 2026-03-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-10 · Grant · Acquired 150,000 · Balance 150,000 F2: Not applicable. F1: The stock options shall vest in four equal quarterly installments (with the first vesting date on June 11, 2026), subject to continued service as a director on each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options shall vest in four equal quarterly installments (with the first vesting date on June 11, 2026), subject to continued service as a director on each applicable vesting date.
F2: Not applicable.
Sonnet BioTherapeutics Holdings, Inc.
Report date April 12, 2019 · Filed May 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,637 |
Reported balance
After 2019-04-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-04-12 · Grant · Acquired 19,304 · Balance 38,637 F1: Shares acquired pursuant to the Issuer's director compensation policy, which permits directors to elect to receive shares of common stock of the Issuer in lieu of receiving their quarterly retainer in cash. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired pursuant to the Issuer's director compensation policy, which permits directors to elect to receive shares of common stock of the Issuer in lieu of receiving their quarterly retainer in cash.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2026 Filed Mar 12, 2026 20:10 UTC | Forward Industries, Inc. FWDI · Entity 5540 | GrantStock Options (Right to Buy) · Derivative | 150,000 | Not disclosed Strike: $5.02 | Not disclosed |
DisclosureSEC source: 0001683168-26-001732 · ownership.xml · derivative · entry 1 Johnson Keith J · CIK 0001484669 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2031-03-10 F2 · price: Not applicable. F1 · derivative.exercise_date: The stock options shall vest in four equal quarterly installments (with the first vesting date on June 11, 2026), subject to continued service as a director on each applicable vesting date. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:03 UTC | Forward Industries, Inc. FORD · Entity 5540 | GrantStock Options (Right to Buy) · Derivative | 12,147 | Not disclosed Strike: $6.37 | Not disclosed |
DisclosureSEC source: 0001683168-25-004190 · ownership.xml · derivative · entry 1 Johnson Keith J · CIK 0001484669 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,147 Underlying: Common Stock · 12,147 shares Expires 2030-06-01 F2 · price: Not applicable. F1 · derivative.exercise_date: The stock options shall vest on June 1, 2026, subject to continued service as a director on the vesting date. Read SEC document |
| January 27, 2023 Filed Apr 7, 2023 16:00 UTC | Amergent Hospitality Group Inc. AMHG · Entity 113007 | GrantCommon Stock | 352,310 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-011558 · ownership.xml · nonDerivative · entry 1 Johnson Keith J · CIK 0001484669 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,879 F1 · price: Non-employee director grant of RSAs, vesting immediately. Read SEC document |
| April 12, 2019 Filed May 14, 2019 20:46 UTC | Sonnet BioTherapeutics Holdings, Inc. BURG · Entity 72220 | GrantCommon Stock | 19,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-007105 · ownership.xml · nonDerivative · entry 1 Johnson Keith J · CIK 0001484669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,637 F1 · security: Shares acquired pursuant to the Issuer's director compensation policy, which permits directors to elect to receive shares of common stock of the Issuer in lieu of receiving their quarterly retainer in cash. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.